Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ambiotex is a German wearable health technology company that develops smart clothing and related software for non-invasive measurement and analysis of vital and movement data. Its core product is an ECG-enabled smart shirt that captures physiological signals such as heart activity, breathing, movement, and stress-related parameters in real time. The company has positioned the technology across sports, workplace safety, lifestyle, and health monitoring use cases, and has described plans to expand from fitness applications toward medically oriented monitoring. ambiotex has collaborated with the Fraunhofer Institute and has been presented as pursuing medical-device oriented applications in addition to consumer and professional monitoring markets. Overall, the business is better characterized as a digital health and wearable device company than as a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ambiotex.